ATE271122T1 - Attenuierter lebender neospora impfstoff - Google Patents

Attenuierter lebender neospora impfstoff

Info

Publication number
ATE271122T1
ATE271122T1 AT97308133T AT97308133T ATE271122T1 AT E271122 T1 ATE271122 T1 AT E271122T1 AT 97308133 T AT97308133 T AT 97308133T AT 97308133 T AT97308133 T AT 97308133T AT E271122 T1 ATE271122 T1 AT E271122T1
Authority
AT
Austria
Prior art keywords
attenuate
live
neospora vaccine
neospora
vaccine
Prior art date
Application number
AT97308133T
Other languages
English (en)
Inventor
David Brake
Byron Blagburn
David Lindsay
Original Assignee
Pfizer
Univ Auburn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21858396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE271122(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer, Univ Auburn filed Critical Pfizer
Application granted granted Critical
Publication of ATE271122T1 publication Critical patent/ATE271122T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97308133T 1996-11-12 1997-10-14 Attenuierter lebender neospora impfstoff ATE271122T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3124896P 1996-11-12 1996-11-12

Publications (1)

Publication Number Publication Date
ATE271122T1 true ATE271122T1 (de) 2004-07-15

Family

ID=21858396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97308133T ATE271122T1 (de) 1996-11-12 1997-10-14 Attenuierter lebender neospora impfstoff

Country Status (16)

Country Link
US (3) US6656479B2 (de)
EP (1) EP0841392B1 (de)
JP (2) JP3690709B2 (de)
CN (2) CN1572322A (de)
AR (2) AR010583A1 (de)
AT (1) ATE271122T1 (de)
AU (1) AU733076B2 (de)
BR (1) BR9705473A (de)
CA (1) CA2220588C (de)
DE (1) DE69729839T2 (de)
DK (1) DK0841392T3 (de)
ES (1) ES2224210T3 (de)
NZ (1) NZ329095A (de)
PT (1) PT841392E (de)
TW (1) TW557214B (de)
ZA (1) ZA9710130B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
BR9803232A (pt) * 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
JP2001520205A (ja) * 1997-10-20 2001-10-30 バイエル・コーポレーシヨン ネオスポラワクチン
EP0953641A3 (de) * 1998-03-26 2002-03-13 Pfizer Products Inc. Für Neospora Proteine kodierende polynukleotid Moleküle
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
AUPQ905600A0 (en) * 2000-07-28 2000-08-24 Insearch Limited Parasites
WO2003038434A2 (en) * 2001-10-31 2003-05-08 Pfizer Products Inc. Serological assay for neospora caninum
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
PT1646715E (pt) 2003-07-22 2010-08-09 Vivalis Produção de poxvírus com linhagem das células aviarias aderentes ou não aderentes
BRPI0417762A8 (pt) * 2003-12-19 2015-12-22 Seattle Biomedical Res Institute Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina
US7722860B2 (en) * 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
CN101506354B (zh) 2006-08-09 2014-05-07 瓦内瓦公司 用胚胎干细胞制备转基因禽类的方法
EP1985305A1 (de) 2007-04-24 2008-10-29 Vivalis Aus Entenembryonen gewonnene Stammzellkulturen zur Herstellung von Impfstoffen gegen Viren
EP1995309A1 (de) * 2007-05-21 2008-11-26 Vivalis Rekombinante Proteinproduktion in EBx -Vogelzellen
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
FR2994193B1 (fr) * 2012-08-02 2016-05-20 Vitamfero Souches mutantes de neospora et leurs utilisations
NZ742210A (en) 2015-10-28 2023-06-30 Univ Madrid Complutense Neospora vaccine composition
CA3037544C (en) 2016-10-05 2021-10-12 Zoetis Services Llc Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines
EP3802841A1 (de) 2018-05-30 2021-04-14 Institute for Research in Biomedicine Manipulation von b-lymphozyten unter verwendung endogener aktivierbarer cytidindesaminase
CN111187721A (zh) * 2020-01-17 2020-05-22 中国农业大学 grx 5基因缺失的新孢子虫弱毒虫株及其构建方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976553A (en) 1993-11-04 1999-11-02 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US6716423B1 (en) * 1994-03-21 2004-04-06 The Regents Of The University Of California Recombinant neospora antigens and their uses
US5707617A (en) 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
WO1997017082A1 (en) * 1995-11-09 1997-05-15 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
US6071737A (en) 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses

Also Published As

Publication number Publication date
ZA9710130B (en) 1999-06-10
JP2005230018A (ja) 2005-09-02
US20020044952A1 (en) 2002-04-18
CA2220588C (en) 2008-07-22
CN1190127A (zh) 1998-08-12
DE69729839T2 (de) 2005-07-21
JPH10167983A (ja) 1998-06-23
JP3935180B2 (ja) 2007-06-20
CN1572322A (zh) 2005-02-02
NZ329095A (en) 1998-03-25
BR9705473A (pt) 1999-04-06
DK0841392T3 (da) 2004-11-22
PT841392E (pt) 2004-11-30
US6656479B2 (en) 2003-12-02
MX9708701A (es) 1998-09-30
EP0841392A3 (de) 1999-03-24
AR053286A2 (es) 2007-04-25
CA2220588A1 (en) 1998-05-12
AR010583A1 (es) 2000-06-28
ES2224210T3 (es) 2005-03-01
US6994861B2 (en) 2006-02-07
US20040062772A1 (en) 2004-04-01
US20060073157A1 (en) 2006-04-06
TW557214B (en) 2003-10-11
JP3690709B2 (ja) 2005-08-31
AU4520397A (en) 1998-05-14
DE69729839D1 (de) 2004-08-19
CN1226406C (zh) 2005-11-09
EP0841392A2 (de) 1998-05-13
EP0841392B1 (de) 2004-07-14
AU733076B2 (en) 2001-05-03

Similar Documents

Publication Publication Date Title
NO991524D0 (no) Vaksiner
NO20003302L (no) Vaksine
DK0841392T3 (da) Svækket levende Neospora vaccine
FI103962B1 (fi) Tarraaja
ID21031A (id) Kornea buatan
ID17860A (id) Komposisi vaksin
DE69726222D1 (de) Photovervielfacher
DE69731046D1 (de) Sicherheitsbehälter
DE69733812D1 (de) Heizkessel
DK0956042T3 (da) Mykosevaccine
PT898969E (pt) Vacina de neospora
FI970176L (fi) Linnunkarkotuslaite
DE69728618D1 (de) Photovervielfacherröhre
FI942438A7 (fi) Hormin tarkastusjärjestely
KR970058619U (ko) 공동용 납골함
NO303371B1 (no) Oppdrettsmerd
ATA46196A (de) Feuerstätte
KR970050586U (ko) 양봉용 먹이통
KR960011347U (ko) 아파트식 분묘
KR970054891U (ko) 트랩
EE9400227A (et) Loomade trihhofüütia vastane vaktsiin
KR980000229U (ko) 주머니가 형성된 각반
NO964478D0 (no) Oppdrettsmerd
KR950026226U (ko) 다슬기포획기
FI962014A0 (fi) Tulisija

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0841392

Country of ref document: EP

REN Ceased due to non-payment of the annual fee